Klinikum Nuernberg

Nuremberg 90419

1 studies enrolling now · 2 studies all time

What they study most

Metastatic Cholangiocarcinoma, Multiple Myeloma, Unresectable Cholangiocarcinoma

Studies at this site

• Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma — Stopped early